The Emirates Drug Authority (EDA) has warned against the risks of using dietary supplements, herbal remedies, weight-loss products and sports performance-enhancement products alongside medications without consulting a doctor or pharmacist. The EDA emphasised that some of these products and herbal substances may alter the absorption, metabolism or effectiveness of medications. It also noted that some products marketed for weight loss or enhanced physical performance may contain undeclared pharmaceutical substances, potentially exposing users to additional health risks, especially when used in high doses or together with other medications.

In exclusive statements to Emarat Al Youm, the EDA explained that Ginkgo biloba, when taken as a dietary supplement, may increase the risk of bleeding when used with certain anticoagulants. St John’s wort may reduce the effectiveness of some medications because of its effect on their metabolism. The authority also cautioned against abruptly discontinuing prescribed medications for chronic diseases, particularly certain epilepsy medications and some corticosteroids (cortisone), which may require a gradual dose reduction under medical supervision, depending on the dosage and duration of use.

EDA confirmed that its regulatory jurisdiction extends to healthcare products that meet approved classifications. Depending on the nature, use and composition of the product, this category includes certain food supplements, herbal products and preparations with a medical effect.

The authority said the regulatory requirements applied to each product vary according to its classification, components, claims and intended use. It stressed that simply labelling a product as “herbal”, “supplement” or “sports product” is not sufficient to determine its regulatory status or safety.

It noted that it handles safety reports related to products within its jurisdiction in accordance with the regulatory requirements applicable to each category, allowing reports to be evaluated and appropriate action taken where necessary.

The authority warned of significant health risks that may arise from combining medications and supplements without medical consultation. It explained that some herbal substances may affect the absorption, metabolism or effectiveness of medicines, and that combining certain preparations with blood-thinning medications may increase the risk of bleeding.

The authority stated that Ginkgo preparations are one example, as they may increase the risk of bleeding when used with certain anticoagulants. Meanwhile, St John’s wort may reduce the effectiveness of certain medicines because of its effect on their metabolism.

The authority pointed to additional risks associated with products marketed for weight loss or enhancing physical performance. It explained that these products may pose risks if they contain undeclared pharmaceutical substances, are used in high doses or are taken alongside other medications.

It stressed the importance of not assuming a product is safe simply because it is described as natural, herbal or a supplement. The authority emphasised the need to know the product’s classification, ingredients, approved information and source before using it.

Regarding treatments prescribed for chronic diseases, the authority advised against stopping them suddenly and without medical consultation, especially epilepsy medications and certain corticosteroids (cortisone), which may require a gradual reduction in dosage under medical supervision depending on the dose and duration of use.

It stressed that discontinuing some treatments could lead to a loss of control over a serious medical condition. The authority noted that any decision to change treatment depends on the type of medication, the health condition and the symptoms involved. Therefore, priority should be given to urgent medical care when warning signs appear, while medical advice should be sought before changing treatment in other situations.

The authority urged members of the public and patients to inform their doctor or pharmacist about all the products they use, including vitamins, herbal products, powders and sports performance supplements, so that specialists can assess the potential for interactions with prescribed medications.

It also recommended checking a product’s source, classification and approved information before use. The authority stressed the importance of keeping details of the packaging, dosage and timing of use if unusual symptoms occur. It also highlighted the need to report suspected adverse effects through the appropriate official channels to allow documentation, evaluation and any necessary action within the relevant jurisdiction.